{"id":30889,"date":"2022-06-27T09:44:57","date_gmt":"2022-06-27T07:44:57","guid":{"rendered":"https:\/\/ellipse.prbb.org\/?p=30889"},"modified":"2022-06-27T09:45:14","modified_gmt":"2022-06-27T07:45:14","slug":"prbbinnovation-el-punt-de-mira-en-la-transferencia-tecnologica","status":"publish","type":"post","link":"https:\/\/ellipse.prbb.org\/ca\/prbbinnovation-el-punt-de-mira-en-la-transferencia-tecnologica\/","title":{"rendered":"#PRBBinnovation: el punt de mira en la transfer\u00e8ncia tecnol\u00f2gica"},"content":{"rendered":"\n

\u201cLes recompenses per a la biotecnologia s\u00f3n extraordin\u00e0ries: guarir malalties, eliminar la pobresa, envellir amb gr\u00e0cia. Sona molt m\u00e9s genial que Facebook<\/strong><\/strong>\u201d<\/strong>
George M. Church, Broad Institute, Harvard<\/p><\/blockquote>\n\n\n\n

<\/p>\n\n\n\n

<\/div>\n\n\n\n

Barcelona s’ha convertit en un actor emergent al panorama europeu de les empreses de ci\u00e8ncies de la vida i de la salut. Segons Biocat<\/a> hi ha 335 empreses biotecnol\u00f2giques<\/strong> amb seu a Catalunya. Cada any es creen m\u00e9s de 20 noves bioempreses i les inversions de capital risc han superat els 200 M\u20ac anuals<\/strong>. Aquestes xifres situen Barcelona i Catalunya dins dels 15 principals hotspots <\/strong>de ci\u00e8ncies de la vida a Europa.<\/p>\n\n\n\n

<\/div>\n\n\n\n
\"\"<\/figure>\n\n\n\n
<\/div>\n\n\n\n

La construcci\u00f3 d’un ecosistema biotecnol\u00f2gic adequat ha trigat 20 anys. La base ha estat una forta comunitat cient\u00edfica local<\/a> <\/strong>i la professionalitzaci\u00f3 de les oficines de transfer\u00e8ncia de tecnologia<\/strong> als centres de recerca i universitats. Posteriorment es van afegir altres elements que faltaven a l’ecosistema: advocats de patents, executives biotech, inversors de capital de risc, ca\u00e7adores de talent<\/strong>, sintonitzar a les companyies farmac\u00e8utiques locals <\/strong>i reduir els obstacles administratius i legals per crear una spin-off a partir una entitat p\u00fablica de recerca.<\/p>\n\n\n\n

<\/div>\n\n\n\n
\"\"<\/figure>\n\n\n\n
<\/div>\n\n\n\n

Investigadors i investigadores dels centres del Parc de Recerca Biom\u00e8dica de Barcelona (PRBB)<\/a> han creat 12 empreses spin-off <\/strong>al llarg dels anys, totes en funcionament i amb \u00e8xit. Els casos d’\u00e8xit recents inclouen Pulmobiotics<\/a><\/strong>, una spin-off del CRG<\/a> que ha recaptat 2 M\u20ac com a capital llavor per desenvolupar bioterap\u00e8utica viva per a malalties respirat\u00f2ries; i Integra Therapeutics<\/a><\/strong>, una spin-off de MELIS-UPF que acaba de tancar una inversi\u00f3 de ronda llavor de 6M\u20ac per dissenyar eines d’edici\u00f3 gen\u00e8tica de propera generaci\u00f3 per curar malalties.<\/p>\n\n\n\n

<\/div>\n\n\n\n
\"\"<\/figure>\n\n\n\n
<\/div>\n\n\n\n

Avui dia, un cient\u00edfic o cient\u00edfica innovadora <\/a>als centres del PRBB troba consultors competents dins de la seva organitzaci\u00f3 per patentar invencions i posteriorment llicenciar-ne la propietat intel\u00b7lectual a les empreses. A m\u00e9s, crear una empresa de nova creaci\u00f3 a Catalunya<\/a> \u00e9s avui menys desafiant que fa nom\u00e9s 5 anys. Finalment, hem arribat a un punt on les innovacions poden sorgir de manera segura i escalar de manera m\u00e9s eficient<\/strong>. Aleshores, si ets una innovadora o un innovador, endavant!<\/p>\n\n\n\n

<\/div>\n\n\n\n
\n\n\n\n
<\/div>\n\n\n\n

Aquest editorial es va publicar al n\u00famero especial de juny del butllet\u00ed El\u00b7lipse<\/a><\/strong>, centrat en la innovaci\u00f3. No et perdis el proper n\u00famero, al juliol, sobre salut mental en l’acad\u00e8mia: Uneix-te a Ellipse ara<\/a>!<\/p>\n","protected":false},"excerpt":{"rendered":"

La 4a edici\u00f3 especial del butllet\u00ed El\u00b7lipse es va centrar en la innovaci\u00f3 i la transfer\u00e8ncia de tecnologia. No et perdis la darrera edici\u00f3, on tractarem el benestar mental a l’\u00e0mbit acad\u00e8mic: #JoinEllipse!<\/p>\n","protected":false},"author":6,"featured_media":30885,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[32],"tags":[726,227,617,589],"new-type":[35],"class_list":["post-30889","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-vida-cientifica","tag-innovacio","tag-prbb-ca","tag-somprbb","tag-tecnologia","new-type-noticies"],"acf":[],"_links":{"self":[{"href":"https:\/\/ellipse.prbb.org\/ca\/wp-json\/wp\/v2\/posts\/30889","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ellipse.prbb.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ellipse.prbb.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ellipse.prbb.org\/ca\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/ellipse.prbb.org\/ca\/wp-json\/wp\/v2\/comments?post=30889"}],"version-history":[{"count":6,"href":"https:\/\/ellipse.prbb.org\/ca\/wp-json\/wp\/v2\/posts\/30889\/revisions"}],"predecessor-version":[{"id":31112,"href":"https:\/\/ellipse.prbb.org\/ca\/wp-json\/wp\/v2\/posts\/30889\/revisions\/31112"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ellipse.prbb.org\/ca\/wp-json\/wp\/v2\/media\/30885"}],"wp:attachment":[{"href":"https:\/\/ellipse.prbb.org\/ca\/wp-json\/wp\/v2\/media?parent=30889"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ellipse.prbb.org\/ca\/wp-json\/wp\/v2\/categories?post=30889"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ellipse.prbb.org\/ca\/wp-json\/wp\/v2\/tags?post=30889"},{"taxonomy":"new-type","embeddable":true,"href":"https:\/\/ellipse.prbb.org\/ca\/wp-json\/wp\/v2\/new-type?post=30889"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}